Literature DB >> 16804026

Alzheimer's disease pathogenesis: role of aging.

Denham Harman1.   

Abstract

Alzheimer's disease (AD) is the chief cause of dementia, and age is its major risk factor. The majority of cases (90-95%) are sporadic (SAD), and the remainder are familial (FAD). AD is characterized by two brain lesions, intraneuronal fibrillary tangles and extracellular plaques. The lesions are identical in SAD and FAD as well as to those in persons with Down's syndrome (DS). The same lesions are also observed frequently in elderly non-demented individuals (E-ND). Both AD lesions may stem from the normal progressive increases in oxidative stress (OxS) throughout the body with age. Onset of dementia due to the accumulating lesions is around 40 years for DS, 40-60 years for FAD, over about 65 years for SAD, while that for E-ND is unknown. The lesions are made clinically manifest with time by the normal increase with age of OxS, "the dementia of old age," or by a process specific for each AD category, which enhances the normal OxS so as to lower the unknown onset age of dementia for E-ND individuals to that associated with the AD category. A plausible process can be advanced for each AD category. The hypothesis suggests convenient, effective measures to prevent and treat, for example, by decreasing brain OxS levels with oral antioxidants such as lipoic or dehydroascorbic acids that are capable of passing the blood-brain barrier.

Entities:  

Mesh:

Year:  2006        PMID: 16804026     DOI: 10.1196/annals.1354.065

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  32 in total

1.  Adaptation and sensitization to proteotoxic stress.

Authors:  Rehana K Leak
Journal:  Dose Response       Date:  2013-08-05       Impact factor: 2.658

Review 2.  Control of mitochondrial integrity in ageing and disease.

Authors:  Radek Szklarczyk; Marco Nooteboom; Heinz D Osiewacz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-07-05       Impact factor: 6.237

3.  Macroautophagy-generated increase of lysosomal amyloid β-protein mediates oxidant-induced apoptosis of cultured neuroblastoma cells.

Authors:  Lin Zheng; Alexei Terman; Martin Hallbeck; Nodi Dehvari; Richard F Cowburn; Eirikur Benedikz; Katarina Kågedal; Angel Cedazo-Minguez; Jan Marcusson
Journal:  Autophagy       Date:  2011-12       Impact factor: 16.016

4.  The effect of iron in MRI and transverse relaxation of amyloid-beta plaques in Alzheimer's disease.

Authors:  Mark D Meadowcroft; Douglas G Peters; Rahul P Dewal; James R Connor; Qing X Yang
Journal:  NMR Biomed       Date:  2014-12-22       Impact factor: 4.044

5.  Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer's disease.

Authors:  C Venkateshappa; G Harish; Anita Mahadevan; M M Srinivas Bharath; S K Shankar
Journal:  Neurochem Res       Date:  2012-03-30       Impact factor: 3.996

6.  Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration.

Authors:  Hu Huang; Sara Van de Veire; Mansi Dalal; Rachel Parlier; Richard D Semba; Peter Carmeliet; Stanley A Vinores
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

7.  Intrinsic voltage dynamics govern the diversity of spontaneous firing profiles in basal forebrain noncholinergic neurons.

Authors:  Saak V Ovsepian; J Oliver Dolly; Laszlo Zaborszky
Journal:  J Neurophysiol       Date:  2012-04-11       Impact factor: 2.714

8.  Oxidative inhibition of protein phosphatase 2A activity: role of catalytic subunit disulfides.

Authors:  Timothy D Foley; Laura A Petro; Coral M Stredny; Teresa M Coppa
Journal:  Neurochem Res       Date:  2007-06-12       Impact factor: 3.996

9.  Therapeutic perspectives of drugs targeting Toll-like receptors based on immune physiopathology theory of Alzheimer's disease.

Authors:  Andrew R Schneider; Youssef Sari
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

Review 10.  Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.

Authors:  Fang Xie; Fangyu Peng
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.